Table 3.
Regression models of the relationship between baseline frontostriatal cerebral blood flow and cardiometabolic risk without systolic blood pressure at follow-up
| Model 1 | Model 2 | Model 3 | |
|---|---|---|---|
| Baseline Frontostriatal CBF | 0.19 ** | 0.18 ** | 0.16 * |
| [0.07, 0.31] | [0.06, 0.31] | [0.03, 0.28] | |
| Baseline Cardiometabolic Risk w/o Blood Pressure | 0.73 *** | 0.73 *** | 0.72 *** |
| [0.61, 0.85] | [0.60, 0.85] | [0.59, 0.85] | |
| Baseline Total CBF | −0.07 | −0.03 | |
| [−0.20, 0.05] | [−0.16, 0.10] | ||
| Age | 0.04 | ||
| [−0.09, 0.17] | |||
| Sex | −0.25 | ||
| [−0.53, 0.02] | |||
| Race | −0.06 | ||
| [−0.34, 0.22] | |||
| Education | 0.04 | ||
| [−0.10, 0.19] | |||
| N | 109 | 109 | 109 |
| R2 | 0.59 | 0.60 | 0.62 |
Standardized regression coefficients are reported with the 95% confidence interval below in brackets. Each model is adjusted for cardiometabolic risk at baseline. Model 1 is unadjusted for any further covariates. Model 2 is adjusted for total cerebral blood flow at baseline. Model 3 is also adjusted for age, sex, race, and education. CBF = Cerebral blood flow;
p < 0.001;
p < 0.01;
p < 0.05.